salicylaldehyde isonicotinoyl hydrazone has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arosio, P; David, S; Jeong, SY; Ponka, P; Rathore, KI; Schulz, K | 1 |
| Domb, A; Golenser, J; Kremsner, P; Leshem, B; Luty, A; Mordechai-Daniel, T | 1 |
| Adamcová, M; Čajnáková, H; Gersl, V; Hrbatová, L; Ponka, P; Popelová, O; Potáčová, A; Šimůnek, T; Sterba, M | 1 |
3 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and Disease Models, Animal
| Article | Year |
|---|---|
Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis.
Topics: Age Factors; Aldehydes; Amyotrophic Lateral Sclerosis; Animals; Body Weight; Cation Transport Proteins; Central Nervous System; Cyclooxygenase 1; Disease Models, Animal; Disease Progression; Ferrozine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Homeostasis; Hydrazones; Indoles; Iron; Iron Chelating Agents; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Mutation; Phosphopyruvate Hydratase; Receptors, Transferrin; Sciatic Neuropathy; Superoxide Dismutase | 2009 |
Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
Topics: Aldehydes; Animals; B-Lymphocytes; Cells, Cultured; Deferoxamine; Disease Models, Animal; Humans; Hydrazones; Interleukin-10; Iron Chelating Agents; Leukocytes, Mononuclear; Luminescence; Malaria; Mice; Plasmodium; Plasmodium falciparum; Survival Analysis; T-Lymphocytes; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Heart Conduction System; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Pyridoxal; Rabbits; Razoxane; Time Factors; Troponin T | 2007 |